![Joseph Walewicz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Walewicz
Direktor/Vorstandsmitglied bei
NEUPATH HEALTH INC.
Vermögen: 565 553 $ am 30.06.2026
Profil
Joseph Walewicz is currently Director at NeuPath Health, Inc. since 2026.
Former positions include Independent Director at Warnex, Inc. from 2011 to 2014; Executive Director of Equity Research at CIBC World Markets, Inc. from 2005 to 2008; Director at Klinik Health Ventures Corp.; Equity Research Associate of Biotechnology at Lehman Brothers, Inc.; Vice President at Paladin Labs, Inc. from 2009 to 2011; Vice President of Equity Research at BMO Nesbitt Burns, Inc. (US); Vice President & Senior Health Care Analyst at Orion Securities, Inc. from 2004 to 2005; Vice President-Business & Corporate Development at Mirati Therapeutics, Inc. from 2011 to 2013; Healthcare Analyst at Laurentian Bank Securities, Inc. from 2014 to 2017; Member at Licensing Executives Society USA & Canada, Inc.; Executive VP-Business & Corporate Development at Clementia Pharmaceuticals, Inc. from 2017 to 2019; and Chief Financial Officer at Fibrocor Therapeutics, Inc. from 2021 to 2022.
Education includes an MBA from McGill University and an undergraduate degree from Queen's University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEUPATH HEALTH INC. 2,24 % | 11.06.2026 | 1.234.832 ( 2,24 % ) | 565 553 $ | 30.06.2026 |
Aktive Positionen von Joseph Walewicz
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUPATH HEALTH INC. | Direktor/Vorstandsmitglied | 25.06.2020 |
Ehemalige bekannte Positionen von Joseph Walewicz
| Unternehmen | Position | Ende |
|---|---|---|
Fibrocor Therapeutics LP
 Fibrocor Therapeutics LP BiotechnologyHealth Technology Develops tissue-specific therapeutics for fibrotic diseases | Finanzdirektor/CFO | 01.03.2022 |
| CLEMENTIA PHARMACEUTICALS INC | Investor Relations Kontakt | 01.01.2019 |
Laurentian Bank Securities, Inc.
 Laurentian Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.04.2017 |
| WARNEX INC. | Direktor/Vorstandsmitglied | 01.01.2014 |
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Joseph Walewicz
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Warnex, Inc.
 Warnex, Inc. Medical SpecialtiesHealth Technology Provides laboratory services to the pharmaceutical and healthcare sectors | Health Technology |
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceuticals | Health Technology |
BMO Nesbitt Burns, Inc. (US) | Finance |
Orion Securities, Inc.
 Orion Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
CIBC World Markets, Inc.
 CIBC World Markets, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laurentian Bank Securities, Inc.
Laurentian Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Licensing Executives Society USA & Canada, Inc.
 Licensing Executives Society USA & Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Operates association for intellectual property, technology, and business development professionals | Commercial Services |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops treatments for patients suffering from bone disorders and other diseases | Health Technology |
Fibrocor Therapeutics LP
Fibrocor Therapeutics LP BiotechnologyHealth Technology Develops tissue-specific therapeutics for fibrotic diseases | Health Technology |
Klinik Health Ventures Corp.
 Klinik Health Ventures Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
NeuPath Health, Inc.
 NeuPath Health, Inc. Financial ConglomeratesFinance Provides chronic pain management services | Finance |
